Female reproduction and type 1 diabetes: From mechanisms to clinical findings

Human Reproduction Update

Volumn 18, Issue 5, 2012, Pages 568-585

  Codner, E ^a   Merino, P M ^a   Tena Sempere, M ^b,c,d  

^a UNIVERSITY OF CHILE   (Chile)

^b UNIVERSITY OF CÓRDOBA   (Spain)

^c Instituto de Salud Carlos III   (Spain)

^d HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

Author keywords

Fertility; Menopause; Ovary; Puberty; Type 1 diabetes mellitus

Indexed keywords

ANDROSTENEDIONE; CORTICOTROPIN; ESTRADIOL; FOLLITROPIN; GONADORELIN; GONADOTROPIN; INSULIN; KISSPEPTIN; LEPTIN; LUTEINIZING HORMONE; MAMMALIAN TARGET OF RAPAMYCIN; MUELLERIAN INHIBITING FACTOR; SEX HORMONE; TESTOSTERONE;

ADOLESCENCE; CHILDHOOD; DELAYED PUBERTY; EARLY MENOPAUSE; ENDOCRINE FUNCTION; ESTRADIOL BLOOD LEVEL; FEMALE FERTILITY; FEMALE INFERTILITY; HIRSUTISM; HORMONE BLOOD LEVEL; HORMONE RELEASE; HUMAN; HYPERANDROGENISM; HYPERGLYCEMIA; HYPERINSULINEMIA; HYPOGONADISM; HYPOTHALAMIC PITUITARY OVARIAN FUNCTION; HYPOTHALAMUS HYPOPHYSIS GONAD SYSTEM; INSULIN DEFICIENCY; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN TREATMENT; LUTEINIZING HORMONE BLOOD LEVEL; MEDLINE; MENARCHE; MENOPAUSE; MENSTRUAL CYCLE; MENSTRUATION DISORDER; METABOLIC REGULATION; METABOLIC STRESS; NONHUMAN; OBESITY; OLIGOMENORRHEA; ONSET AGE; OVARY FOLLICLE DEVELOPMENT; OVARY FUNCTION; OVARY POLYCYSTIC DISEASE; OVULATION; PATHOPHYSIOLOGY; POLYMENORRHEA; PRECOCIOUS PUBERTY; PREMENOPAUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PUBERTY; REPRODUCTION; REVIEW; SECONDARY AMENORRHEA; TESTOSTERONE BLOOD LEVEL; WEIGHT GAIN;

AMENORRHEA; ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; HYPERANDROGENISM; HYPOGONADISM; INSULIN; MENARCHE; MENSTRUATION DISTURBANCES; OLIGOMENORRHEA; POLYCYSTIC OVARY SYNDROME; PREGNANCY; PUBERTY, DELAYED; REPRODUCTION;

EID: 84865087203     PISSN: 13554786     EISSN: 14602369     Source Type: Journal    
DOI: 10.1093/humupd/dms024     Document Type: Review

References (205)

1. Adcock CJ, Perry LA, Lindsell DR, Taylor AM, Holly JM, Jones J, Dunger DB. Menstrual irregularities are more common in adolescents with type 1 diabetes: association with poor glycaemic control and weight gain. Diabet Med 1994; 11:465-470.
2. Ahmed ML, Connors MH, Drayer NM, Jones JS, Dunger DB. Pubertal growth in IDDM is determined by HbA1c levels, sex, and bone age. Diabetes Care 1998; 21:831-835.
3. American Academy of Pediatrics, Committee on Adolescence, American College of Obstetricians and Gynecologists and Committee on Adolescent Health Care Menstruation in Girls and Adolescents. Using the menstrual cycle as a vital sign. Pediatrics 2006;118:2245-2250.
4. American College of Obstetrics and Gynecology. ACOG Committee Opinion No. 349, November 2006: menstruation in girls and adolescents: using the menstrual cycle as a vital sign. Obstet Gynecol 2006;108:1323-1328.
5. Amiel SA, Sherwin RS, Simonson DC, Lauritano AA, Tamborlane WV. Impaired insulin action in puberty. A contributing factor to poor glycemic control in adolescents with diabetes. N Engl J Med 1986;315:215-219.
6. Amin R, Schultz C, Ong K, Frystyk J, Dalton RN, Perry L, Orskov H, Dunger DB. Low IGF-I and elevated testosterone during puberty in subjects with type 1 diabetes developing microalbuminuria in comparison to normoalbuminuric control subjects: the Oxford Regional Prospective Study. Diabetes Care 2003; 26:1456-1461.
7. Arrais RF, Dib SA. The hypothalamus-pituitary-ovary axis and type 1 diabetes mellitus: a mini review. Hum Reprod 2006;21:327-337.
8. Arslanian SA, Heil BV, Becker DJ, Drash AL. Sexual dimorphism in insulin sensitivity in adolescents with insulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1991;72:920-926.
9. Asuncion M, Calvo RM, San Millan JL, Sancho J, Avila S, Escobar-Morreale HF. A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. J Clin Endocrinol Metab 2000; 85:2434-2438.
10. Auchus RJ. The physiology and biochemistry of adrenarche. Endocr Dev 2011; 20:20-27.
11. Backholer K, Bowden M, Gamber K, Bjorbaek C, Iqbal J, Clarke IJ. Melanocortins mimic the effects of leptin to restore reproductive function in lean hypogonadotropic ewes. Neuroendocrinology 2010a;91:27-40.
12. Backholer K, Smith JT, Rao A, Pereira A, Iqbal J, Ogawa S, Li Q, Clarke IJ. Kisspeptin cells in the ewe brain respond to leptin and communicate with neuropeptide Y and proopiomelanocortin cells. Endocrinology 2010b;151:2233-2243.
13. Beckers D, Ahmed ML, Sancho PC, Acerini CL, Edge JA, De Zegher F, Ibanez L, Dunger DB. Adolescent girls with TIDM, does combination treatment with flutamide and metformin make a difference? Pediatr Diabetes 2006;7(S5):56.
14. Berg TJ, Dahl-Jorgensen K, Torjesen PA, Hanssen KF. Increased serum levels of advanced glycation end products (AGEs) in children and adolescents with IDDM. Diabetes Care 1997;20:1006-1008.
15. Bergh C, Carlsson B, Olsson JH, Selleskog U, Hillensjo T. Regulation of androgen production in cultured human thecal cells by insulin-like growth factor I and insulin. Fertil Steril 1993;59:323-331.
16. Bergqvist N. The gonadal function in female diabetics. Acta Endocrinol Suppl (Copenh) 1954;19:1-20.
17. Bestetti GE, Junker U, Locatelli V, Rossi GL. Continuous subtherapeutic insulin counteracts hypothalamopituitary-gonadal alterations in diabetic rats. Diabetes 1987;36:1315-1319.
18. Bizzarri C, Benevento D, Rava L, Patera IP, Schiaffini R, Ciampalini P, Giannone G, Cappa M. Ovarian hyperandrogenism in adolescents and young women with type I diabetes is primarily related to birth weight and body mass index. Fertil Steril 2011;96:1497-1502 e1491.
19. Bolli GB. Physiological insulin replacement in type 1 diabetes mellitus. Exp Clin Endocrinol Diabetes 2001;109(Suppl 2):S317-S332.
20. Bowton PA, Bryant KR, Whitehead SA. Feedback effects of gonadal steroids and pituitary LH-releasing hormone receptors in the streptozotocin-induced diabetic rat. Acta Endocrinol (Copenh) 1986;111:467-473.
21. Bruning JC, Gautam D, Burks DJ, Gillette J, Schubert M, Orban PC, Klein R, Krone W, Muller-Wieland D, Kahn CR. Role of brain insulin receptor in control of body weight and reproduction. Science 2000;289:2122-2125.
22. Bryden KS, Peveler RC, Stein A, Neil A, Mayou RA, Dunger DB. Clinical and psychological course of diabetes from adolescence to young adulthood: a longitudinal cohort study. Diabetes Care 2001;24:1536-1540.
23. Burcelin R, Thorens B, Glauser M, Gaillard RC, Pralong FP. Gonadotropin-releasing hormone secretion from hypothalamic neurons: stimulation by insulin and potentiation by leptin. Endocrinology 2003;144:4484-4491.
24. Cara JF, Rosenfield RL. Insulin-like growth factor I and insulin potentiate luteinizing hormone-induced androgen synthesis by rat ovarian thecal-interstitial cells. Endocrinology 1988;123:733-739.
25. Caruso S, Rugolo S, Agnello C, Intelisano G, Di Mari L, Cianci A. Sildenafil improves sexual functioning in premenopausal women with type 1 diabetes who are affected by sexual arousal disorder: a double-blind, crossover, placebo-controlled pilot study. Fertil Steril 2006a;85:1496-1501.
26. Caruso S, Rugolo S, Mirabella D, Intelisano G, Di Mari L, Cianci A. Changes in clitoral blood flow in premenopausal women affected by type 1 diabetes after single 100-mg administration of sildenafil. Urology 2006b;68:161-165.
27. Castellano JM, Navarro VM, Fernandez-Fernandez R, Nogueiras R, Tovar S, Roa J, Vazquez MJ, Vigo E, Casanueva FF, Aguilar E et al. Changes in hypothalamic KiSS-1 system and restoration of pubertal activation of the reproductive axis by kisspeptin in undernutrition. Endocrinology 2005;146:3917-3925.
28. Castellano JM, Navarro VM, Fernandez-Fernandez R, Roa J, Vigo E, Pineda R, Dieguez C, Aguilar E, Pinilla L, Tena-Sempere M. Expression of hypothalamic KiSS-1 system and rescue of defective gonadotropic responses by kisspeptin in streptozotocin-induced diabetic male rats. Diabetes 2006;55:2602-2610.
29. Castellano JM, Navarro VM, Roa J, Pineda R, Sanchez-Garrido MA, Garcia-Galiano D, Vigo E, Dieguez C, Aguilar E, Pinilla L et al. Alterations in hypothalamic KiSS-1 system in experimental diabetes: early changes and functional consequences. Endocrinology 2009;150:784-794.
30. Castellano JM, Bentsen AH, Mikkelsen JD, Tena-Sempere M. Kisspeptins: bridging energy homeostasis and reproduction. Brain Res 2010a;1364:129-138.
31. Castellano JM, Bentsen AH, Romero M, Pineda R, Ruiz-Pino F, Garcia-Galiano D, Sanchez-Garrido MA, Pinilla L, Mikkelsen JD, Tena-Sempere M. Acute inflammation reduces kisspeptin immunoreactivity at the arcuate nucleus and decreases responsiveness to kisspeptin independently of its anorectic effects. Am J Physiol Endocrinol Metab 2010b;299:E54-E61.
32. Cawood EH, Bancroft J, Steel JM. Perimenstrual symptoms in women with diabetes mellitus and the relationship to diabetic control. Diabet Med 1993; 10:444-448.
33. Clarson C, Daneman D, Ehrlich RM. The relationship of metabolic control to growth and pubertal development in children with insulin-dependent diabetes. Diabetes Res 1985;2:237-241.
34. Codner E. Estrogen and type 1 diabetes mellitus. Pediatr Endocrinol Rev 2008; 6:228-234.
35. Codner E, Cassorla F. Puberty and ovarian function in girls with type 1 diabetes mellitus. Horm Res 2009;71:12-21.
36. Codner E, Escobar-Morreale HF. Clinical review: hyperandrogenism and polycystic ovary syndrome in women with type 1 diabetes mellitus. J Clin Endocrinol Metab 2007;92:1209-1216.
37. Codner E, Barrera A, Mook-Kanamori D, Bazaes RA, Unanue N, Gaete X, Avila A, Ugarte F, Torrealba I, Perez V et al. Ponderal gain, waist-to-hip ratio, and pubertal development in girls with type-1 diabetes mellitus. Pediatr Diabetes 2004; 5:182-189.
38. Codner E, Mook-Kanamori D, Bazaes RA, Unanue N, Sovino H, Ugarte F, Avila A, Iniguez G, Cassorla F. Ovarian function during puberty in girls with type 1 diabetes mellitus: response to leuprolide. J Clin Endocrinol Metab 2005;90:3939-3945.
39. Codner E, Soto N, Lopez P, Trejo L, Avila A, Eyzaguirre FC, Iniguez G, Cassorla F. Diagnostic criteria for polycystic ovary syndrome and ovarian morphology in women with type 1 diabetes mellitus. J Clin Endocrinol Metab 2006; 91:2250-2256.
40. Codner E, Iniguez G, Villarroel C, Lopez P, Soto N, Sir-Petermann T, Cassorla F, Rey RA. Hormonal profile in women with polycystic ovarian syndrome with or without type 1 diabetes mellitus. J Clin Endocrinol Metab 2007;92:4742-4746.
41. Codner E, Iniguez G, Lopez P, Eyzaguirre F, Asenjo S, Torrealba I, Perez-Bravo F, Cassorla F. Metformin for the treatment of hyperandrogenism in adolescents with type 1 diabetes mellitus: a double blind randomized study. Horm Res 2009;72:431.
42. Codner E, Eyzaguirre FC, Iniguez G, Lopez P, Perez-Bravo F, Torrealba IM, Cassorla F. Chilean group for the study of ovarian function in type, D. Ovulation rate in adolescents with type 1 diabetes mellitus. Fertil Steril 2011a;95:197-202, 202 e191.
43. Codner E, Iniguez G, Hernandez IM, Lopez P, Rhumie HK, Villarroel C, Rey RA. Elevated anti-Mullerian hormone (AMH) and inhibin B levels in prepubertal girls with type 1 diabetes mellitus. Clin Endocrinol (Oxf) 2011b;74:73-78.
44. Codner E, Soto N, Merino PM. Contraception, and pregnancy in adolescents with type 1 diabetes: a review. Pediatr Diabetes 2012;13:108-123.
45. Constantin S. Physiology of the gonadotrophin-releasing hormone (GnRH) neurone: studies from embryonic GnRH neurones. J Neuroendocrinol 2011; 23:542-553.
46. Cunningham MJ, Clifton DK, Steiner RA. Leptin's actions on the reproductive axis: perspectives and mechanisms. Biol Reprod 1999;60:216-222.
47. Chabrolle C, Jeanpierre E, Tosca L, Rame C, Dupont J. Effects of high levels of glucose on the steroidogenesis and the expression of adiponectin receptors in rat ovarian cells. Reprod Biol Endocrinol 2008;6:11.
48. Chandrashekar V, Steger RW, Bartke A, Fadden CT, Kienast SG. Influence of diabetes on the gonadotropin response to the negative feedback effect of testosterone and hypothalamic neurotransmitter turnover in adult male rats. Neuroendocrinology 1991;54:30-35.
49. Chang AS, Dale AN, Moley KH. Maternal diabetes adversely affects preovulatory oocyte maturation, development, and granulosa cell apoptosis. Endocrinology 2005;146:2445-2453.
50. Chaplen FW, Fahl WE, Cameron DC. Evidence of high levels of methylglyoxal in cultured Chinese hamster ovary cells. Proc Natl Acad Sci USA 1998; 95:5533-5538.
51. Christensen NJ. Abnormally high plasma catecholamines at rest and during exercise in ketotic juvenile diabetics. Scand J Clin Lab Invest 1970;26:343-344.
52. Danielson KK, Palta M, Allen C, D'Alessio DJ. The association of increased total glycosylated hemoglobin levels with delayed age at menarche in young women with type 1 diabetes. J Clin Endocrinol Metab, 2005;90:6466-6471.
53. Danne T, Kordonouri O, Enders I, Weber B. Factors influencing height and weight development in children with diabetes. Results of the Berlin retinopathy study. Diabetes Care 1997;20:281-285.
54. de Beaufort CE, Swift PG, Skinner CT, Aanstoot HJ, Aman J, Cameron F, Martul P, Chiarelli F, Daneman D, Danne T et al. Continuing stability of center differences in pediatric diabetes care: do advances in diabetes treatment improve outcome? The Hvidoere Study Group on Childhood Diabetes. Diabetes Care 2007; 30:2245-2250.
55. Deltsidou A. Age at menarche and menstrual irregularities of adolescents with type 1 diabetes. J Pediatr Adolesc Gynecol 2010;23:162-167.
56. Deltsidou A, Lemonidou C, Zarikas V, Matziou V, Bartsocas CS. Oligomenorrhoea in adolescents with type 1 diabetes mellitus: relationship to glycaemic control. Eur J Obstet Gynecol Reprod Biol 2010;153:62-66.
57. Diamanti-Kandarakis E, Piperi C, Korkolopoulou P, Kandaraki E, Levidou G, Papalois A, Patsouris E, Papavassiliou AG. Accumulation of dietary glycotoxins in the reproductive system of normal female rats. J Mol Med (Berl) 2007a; 85:1413-1420.
58. Diamanti-Kandarakis E, Piperi C, Patsouris E, Korkolopoulou P, Panidis D, Pawelczyk L, Papavassiliou AG, Duleba AJ. Immunohistochemical localization of advanced glycation end-products (AGEs) and their receptor (RAGE) in polycystic and normal ovaries. Histochem Cell Biol 2007b;127:581-589.
59. Dicker D, Ben-Rafael Z, Ashkenazi J, Feldberg D. In vitro fertilization and embryo transfer in well-controlled, insulin-dependent diabetics. Fertil Steril 1992; 58:430-432.
60. Distiller LA, Sagel J, Morley JE, Seftel HC. Pituitary responsiveness to luteinizing hormone-releasing hormone in insulin-dependent diabetes mellitus. Diabetes 1975;24:378-380.
61. Djursing H, Nyholm HC, Hagen C, Carstensen L, Pedersen LM. Clinical and hormonal characteristics in women with anovulation and insulin-treated diabetes mellitus. Am J Obstet Gynecol 1982;143:876-882.
62. Djursing H, Hagen C, Nyholm HC, Carstensen L, Andersen AN. Gonadotropin responses to gonadotropin-releasing hormone and prolactin responses to thyrotropin-releasing hormone and metoclopramide in women with amenorrhea and insulin-treated diabetes mellitus. J Clin Endocrinol Metab 1983; 56:1016-1021.
63. Djursing H, Andersen AN, Hagen C, Petersen K. Gonadotropin secretion before and during acute and chronic dopamine-receptor blockade in insulin-dependent diabetic patients with amenorrhea. Fertil Steril 1985a;44:49-55.
64. Djursing H, Hagen C, Nyboe Andersen A, Svenstrup B, Bennett P, Molsted Pedersen L. Serum sex hormone concentrations in insulin dependent diabetic women with and without amenorrhoea. Clin Endocrinol (Oxf) 1985b;23:147-154.
65. Dong Q, Lazarus RM, Wong LS, Vellios M, Handelsman DJ. Pulsatile LH secretion in streptozotocin-induced diabetes in the rat. J Endocrinol 1991;131:49-55.
66. Dorman JS, Steenkiste AR, Foley TP, Strotmeyer ES, Burke JP, Kuller LH, Kwoh CK. Menopause in type 1 diabetic women: is it premature? Diabetes 2001; 50:1857-1862.
67. Du Caju MV, Rooman RP, op de Beeck L. Longitudinal data on growth and final height in diabetic children. Pediatr Res 1995;38:607-611.
68. Enzlin P, Mathieu C, Van den Bruel A, Bosteels J, Vanderschueren D, Demyttenaere K. Sexual dysfunction in women with type 1 diabetes: a controlled study. Diabetes Care 2002;25:672-677.
69. Enzlin P, Mathieu C, Van Den Bruel A, Vanderschueren D, Demyttenaere K. Prevalence and predictors of sexual dysfunction in patients with type 1 diabetes. Diabetes Care 2003;26:409-414.
70. Escobar-Morreale HF, Roldan B, Barrio R, Alonso M, Sancho J, de la Calle H, Garcia-Robles R. High prevalence of the polycystic ovary syndrome and hirsutism in women with type 1 diabetes mellitus. J Clin Endocrinol Metab 2000; 85:4182-4187.
71. Eyzaguirre CF, Codner E. Insulin analogues: searching for a physiological replacement. Rev Med Chil 2006;134:239-250.
72. Fernandez-Fernandez R, Martini AC, Navarro VM, Castellano JM, Dieguez C, Aguilar E, Pinilla L, Tena-Sempere M. Novel signals for the integration of energy balance and reproduction. Mol Cell Endocrinol 2006;254-255:127-132.
73. Ferrante E, Pitzalis G, Vania A, De Angelis P, Guidi R, Fontana L, Ferrante L, Cervoni M, Multari G. Nutritional status, obesity and metabolic control in children with type 1 diabetes mellitus. Minerva Pediatr 1999;51:39-46.
74. Fluck CE, Kuhlmann BV, Mullis PE. Insulin increases serum leptin concentrations in children and adolescents with newly diagnosed type I diabetes mellitus with and without ketoacidosis. Diabetologia 1999;42:1067-1070.
75. Fu LY, van den Pol AN. Kisspeptin directly excites anorexigenic proopiomelanocortin neurons but inhibits orexigenic neuropeptide Y cells by an indirect synaptic mechanism. J Neurosci 2010;30:10205-10219.
76. Fulghesu AM, Villa P, Pavone V, Guido M, Apa R, Caruso A, Lanzone A, Rossodivita A, Mancuso S. The impact of insulin secretion on the ovarian response to exogenous gonadotropins in polycystic ovary syndrome. J Clin Endocrinol Metab 1997;82:644-648.
77. Gaete X, Vivanco M, Eyzaguirre FC, López P, Rhumie HK, Unanue N, Codner E. Menstrual cycle irregularities and their relationship with HbA1c and insulin dose in adolescents with type 1 diabetes mellitus. Fertil Steril 2010;94:1822-1826.
78. Garcia-Galiano D, Pinilla L, Tena-Sempere M. Sex steroids and the control of the Kiss1 system: developmental roles and major regulatory actions. J Neuroendocrinol 2012;24:22-33.
79. Gilbert JA, Dunlop DM. Diabetic fertility, maternal mortality, and foetal loss rate. Br Med J 1949;1:48-51.
80. Goldner WS, Kraus VL, Sivitz WI, Hunter SK, Dillon JS. Cyclic changes in glycemia assessed by continuous glucose monitoring system during multiple complete menstrual cycles in women with type 1 diabetes. Diabetes Technol Ther 2004; 6:473-480.
81. Gougeon A. Regulation of ovarian follicular development in primates: facts and hypotheses. Endocr Rev 1996;17:121-155.
82. Griffin ML, South SA, Yankov VI, Booth RA Jr, Asplin CM, Veldhuis JD, Evans WS. Insulin-dependent diabetes mellitus and menstrual dysfunction. Ann Med 1994; 26:331-340.
83. Groome NP, Illingworth PJ, O'Brien M, Pai R, Rodger FE, Mather JP, McNeilly AS. Measurement of dimeric inhibin B throughout the human menstrual cycle. J Clin Endocrinol Metab 1996;81:1401-1405.
84. Hargreave TB, Mills JA. Investigating and managing infertility in general practice. Br Med J 1998;316:1438-1441.
85. Healy DL, Trounson AO, Andersen AN. Female infertility: causes and treatment. Lancet 1994;343:1539-1544.
86. Herring J, Gearhart J. Assessment of premenstrual glycemic control in an insulin dependent woman. J Miss State Med Assoc 1996;37:513-514.
87. Hill JW, Elmquist JK, Elias CF. Hypothalamic pathways linking energy balance and reproduction. Am J Physiol Endocrinol Metab 2008;294:E827-E832.
88. Hovav Y, Almagor M, Kafka I, Elgavish G, Yaffe H. In vitro fertilization and embryo transfer in uncontrolled diabetes mellitus. J Assist Reprod Genet 1995;12:392-393.
89. Hsueh AJ, Billig H, Tsafriri A. Ovarian follicle atresia: a hormonally controlled apoptotic process. Endocr Rev 1994;15:707-724.
90. Ibanez L, Potau N, Virdis R, Zampolli M, Terzi C, Gussinye M, Carrascosa A, Vicens-Calvet E. Postpubertal outcome in girls diagnosed of premature pubarche during childhood: increased frequency of functional ovarian hyperandrogenism. J Clin Endocrinol Metab 1993;76:1599-1603.
91. Ibanez L, Potau N, Zampolli M, Street ME, Carrascosa A. Girls diagnosed with premature pubarche show an exaggerated ovarian androgen synthesis from the early stages of puberty: evidence from gonadotropin-releasing hormone agonist testing. Fertil Steril 1997;67:849-855.
92. Ibanez L, Potau N, Francois I, de Zegher F. Precocious pubarche, hyperinsulinism, and ovarian hyperandrogenism in girls: relation to reduced fetal growth. J Clin Endocrinol Metab 1998;83:3558-3562.
93. Ibanez L, Dimartino-Nardi J, Potau N, Saenger P. Premature adrenarche-normal variant or forerunner of adult disease? Endocr Rev 2000;21:671-696.
94. Iniguez G, Torrealba IM, Avila A, Cassorla F, Codner E. Adiponectin serum levels and their relationships to androgen concentrations and ovarian volume during puberty in girls with type 1 diabetes mellitus. Horm Res 2008; 70:112-117.
95. Jonasson JM, Brismar K, Sparen P, Lambe M, Nyren O, Ostenson CG, Ye W. Fertility in women with type 1 diabetes: a population-based cohort study in Sweden. Diabetes Care 2007;30:2271-2276.
96. Kalamatianos T, Grimshaw SE, Poorun R, Hahn JD, Coen CW. Fasting reduces KiSS-1 expression in the anteroventral periventricular nucleus (AVPV): effects of fasting on the expression of KiSS-1 and neuropeptide Y in the AVPV or arcuate nucleus of female rats. J Neuroendocrinol 2008;20:1089-1097.
97. Katayama S, Brownscheidle CM, Wootten V, Lee JB, Shimaoka K. Absent or delayed preovulatory luteinizing hormone surge in experimental diabetes mellitus. Diabetes 1984;33:324-327.
98. Kezele PR, Nilsson EE, Skinner MK. Insulin but not insulin-like growth factor-1 promotes the primordial to primary follicle transition. Mol Cell Endocrinol 2002; 192:37-43.
99. Kienast SG, Fadden C, Steger RW. Streptozotocin-induced diabetes blocks the positive feedback release of luteinizing hormone in the female rat. Brain Res Bull 1993;32:399-405.
100. Kim GL, Dhillon SS, Belsham DD. Kisspeptin directly regulates neuropeptide Y synthesis and secretion via the ERK1/2 and p38 mitogen-activated protein kinase signaling pathways in NPY-secreting hypothalamic neurons. Endocrinology 2010;151:5038-5047.
101. Kjaer K, Hagen C, Sando SH, Eshoj O. Epidemiology of menarche and menstrual disturbances in an unselected group of women with insulin-dependent diabetes mellitus compared to controls. J Clin Endocrinol Metab 1992a; 75:524-529.
102. Kjaer K, Hagen C, Sando SH, Eshoj O. Infertility and pregnancy outcome in an unselected group of women with insulin-dependent diabetes mellitus. Am J Obstet Gynecol 1992b;166:1412-1418.
103. Knight PG, Glister C. Potential local regulatory functions of inhibins, activins and follistatin in the ovary. Reproduction 2001;121:503-512.
104. Kryshak EJ, Butler PC, Marsh C, Miller A, Barr D, Polonsky K, Perkins JD, Rizza RA. Pattern of postprandial carbohydrate metabolism and effects of portal and peripheral insulin delivery. Diabetes 1990;39:142-148.
105. La Marca A, Morgante G, De Leo V. Evaluation of hypothalamic-pituitary-adrenal axis in amenorrhoeic women with insulin-dependent diabetes. Hum Reprod 1999;14:298-302.
106. Laing SP, Swerdlow AJ, Slater SD, Burden AC, Morris A, Waugh NR, Gatling W, Bingley PJ, Patterson CC. Mortality from heart disease in a cohort of 23,000 patients with insulin-treated diabetes. Diabetologia 2003;46:760-765.
107. Letterie GS, Fredlund PN. Catamenial insulin reactions treated with a long-acting gonadotropin releasing hormone agonist. Arch Intern Med 1994; 154:1868-1870.
108. Li Voon Chong DJSW. Focus on catamenial hyperglycaemia. Practical Diabetes Int 2010;27:384-384.
109. Livshits A, Seidman DS. Fertility issues in women with diabetes. Womens Health (Lond Engl) 2009;5:701-707.
110. Lombardo F, Salzano G, Crisafulli G, Valenzise M, Zirilli G, Manzo V, Aversa T, De Luca F. Menarcheal timing in intensively treated girls with type 1 diabetes mellitus. Nutr Metab Cardiovasc Dis 2009;19:35-38.
111. Lunt H, Brown LJ. Self-reported changes in capillary glucose and insulin requirements during the menstrual cycle. Diabet Med 1996;13:525-530.
112. Luque RM, Kineman RD, Tena-Sempere M. Regulation of hypothalamic expression of KiSS-1 and GPR54 genes by metabolic factors: analyses using mouse models and a cell line. Endocrinology 2007;148:4601-4611.
113. Lloyd CE, Kuller LH, Ellis D, Becker DJ, Wing RR, Orchard TJ. Coronary artery disease in IDDM. Gender differences in risk factors but not risk. Arterioscler Thromb Vasc Biol 1996;16:720-726.
114. Maliqueo M, Sir-Petermann T, Perez V, Echiburu B, Ladron de Guevara A, Galvez C, Crisosto N, Azziz R. Adrenal function during childhood and puberty in daughters of women with polycystic ovary syndrome. J Clin Endocrinol Metab 2009; 94:3282-3288.
115. Mauriac P. Gros ventre, hepatomegalie, troubles de la croissance chez les enfants diabetiques, traites depuis plusieury annes par l'insuline. Gaz Hebd Sci Med Bordeaux 1930;51:402.
116. Mestman JH. Historical notes on diabetes and pregnancy. Endocrinologist 2002; 12:224-242.
117. Meyer K, Deutscher J, Anil M, Berthold A, Bartsch M, Kiess W. Serum androgen levels in adolescents with type 1 diabetes: relationship to pubertal stage and metabolic control. J Endocrinol Invest 2000;23:362-368.
118. Moberg E, Kollind M, Lins PE, Adamson U. Day-to-day variation of insulin sensitivity in patients with type 1 diabetes: role of gender and menstrual cycle. Diabet Med 1995;12:224-228.
119. Moran A, Jacobs DR Jr, Steinberger J, Steffen LM, Pankow JS, Hong C-P, Sinaiko AR. Changes in insulin resistance and cardiovascular risk during adolescence: establishment of differential risk in males and females. Circulation 2008; 117:2361-2368.
120. Nishimura E, Soderlund D, Castro-Fernandez C, Zarinan T, Mendez JP, Ulloa-Aguirre A. In vitro biological-to-immunological ratio of serum gonadotropins throughout male puberty in children with insulin-dependent diabetes mellitus. Endocrine 2007;31:18-26.
121. Oakley AE, Clifton DK, Steiner RA. Kisspeptin signaling in the brain. Endocr Rev 2009;30:713-743.
122. O'Hare JA, Eichold Ii BH, Vignati L. Hypogonadotropic secondary amenorrhea in diabetes: effects of central opiate blockade and improved metabolic control. Am J Med 1987;83:1080-1084.
123. Orchard TJ, Costacou T, Kretowski A, Nesto RW. Type 1 diabetes and coronary artery disease. Diabetes Care 2006;29:2528-2538.
124. Pal L, Chu HP, Shu J, Topalli I, Santoro N, Karkanias G. In vitro evidence of glucose-induced toxicity in GnRH secreting neurons: high glucose concentrations influence GnRH secretion, impair cell viability, and induce apoptosis in the GT1-1 neuronal cell line. Fertil Steril 2007;88:1143-1149.
125. Parent AS, Teilmann G, Juul A, Skakkebaek NE, Toppari J, Bourguignon JP. The timing of normal puberty and the age limits of sexual precocity: variations around the world, secular trends, and changes after migration. Endocr Rev 2003;24:668-693.
126. Pedersen KK, Hagen C, Sando-Pedersen SH, Eshoj O. Infertility and pregnancy outcome in women with insulin-dependent diabetes. An epidemiological study. Ugeskr Laeger 1994;156:6196-6200.
127. Picardi A, Cipponeri E, Bizzarri C, Fallucca S, Guglielmi C, Pozzilli P. Menarche in type 1 diabetes is still delayed despite good metabolic control. Fertil Steril 2008; 90:1875-1877.
128. Polonsky KS, Given BD, Hirsch L, Shapiro ET, Tillil H, Beebe C, Galloway JA, Frank BH, Karrison T, Van Cauter E. Quantitative study of insulin secretion and clearance in normal and obese subjects. J Clin Invest 1988;81:435-441.
129. Poretsky L, Kalin MF. The gonadotropic function of insulin. Endocr Rev 1987; 8:132-141.
130. Poretsky L, Clemons J, Bogovich K. Hyperinsulinemia and human chorionic gonadotropin synergistically promote the growth of ovarian follicular cysts in rats. Metabolism 1992;41:903-910.
131. Poretsky L, Cataldo NA, Rosenwaks Z, Giudice LC. The insulin-related ovarian regulatory system in health and disease. Endocr Rev 1999;20:535-582.
132. Powers RW, Chambers C, Larsen WJ. Diabetes-mediated decreases in ovarian superoxide dismutase activity are related to blood-follicle barrier and ovulation defects. Endocrinology 1996;137:3101-3110.
133. Pralong FP. Insulin and NPY pathways and the control of GnRH function and puberty onset. Mol Cell Endocrinol 2010;324:82-86.
134. Prelevic GM, Wurzburger MI, Peric LA. The effect of residual beta cell activity on menstruation and the reproductive hormone profile of insulin-dependent diabetics. Arch Gynecol Obstet 1989;244:207-213.
135. Remer T, Maser-Gluth C, Boye KR, Hartmann MF, Heinze E, Wudy SA. Exaggerated adrenarche and altered cortisol metabolism in Type 1 diabetic children. Steroids 2006;71:591-598.
136. Riihimaa PH, Knip M, Hirvela H, Tapanainen P. Metabolic characteristics and urine albumin excretion rate in relation to pubertal maturation in Type 1 diabetes. Diabetes Metab Res Rev 2000;16:269-275.
137. Rizza RA, Gerich JE, Haymond MW, Westland RE, Hall LD, Clemens AH, Service FJ. Control of blood sugar in insulin-dependent diabetes: comparison of an artificial endocrine pancreas, continuous subcutaneous insulin infusion, and intensified conventional insulin therapy. N Engl J Med 1980;303:1313-1318.
138. Roa J, Tena-Sempere M. Energy balance and puberty onset: emerging role of central mTOR signaling. Trends Endocrinol Metab 2010;21:519-528.
139. Roa J, Aguilar E, Dieguez C, Pinilla L, Tena-Sempere M. New frontiers in kisspeptin/ GPR54 physiology as fundamental gatekeepers of reproductive function. Front Neuroendocrinol 2008;29:48-69.
140. Roa J, Garcia-Galiano D, Varela L, Sanchez-Garrido MA, Pineda R, Castellano JM, Ruiz-Pino F, Romero M, Aguilar E, Lopez M et al. The mammalian target of rapamycin as novel central regulator of puberty onset via modulation of hypothalamic Kiss1 system. Endocrinology 2009;150:5016-5026.
141. Roa J, Garcia-Galiano D, Castellano JM, Gaytan F, Pinilla L, Tena-Sempere M. Metabolic control of puberty onset: new players, new mechanisms. Mol Cell Endocrinol 2010;324:87-94.
142. Roa J, Navarro VM, Tena-Sempere M. Kisspeptins in reproductive biology: consensus knowledge and recent developments. Biol Reprod 2011;85:650-660.
143. Rohrer T, Stierkorb E, Heger S, Karges B, Raile K, Schwab KO, Holl RW. Delayed pubertal onset and development in German children and adolescents with type 1 diabetes: cross-sectional analysis of recent data from the DPV diabetes documentation and quality management system. Eur J Endocrinol 2007; 157:647-653.
144. Rohrer T, Stierkorb E, Grabert M, Holterhus PM, Kapellen T, Knerr I, Mix M, Holl RW. Delayed menarche in young German women with type 1 diabetes mellitus: recent results from the DPV diabetes documentation and quality management system. Eur J Pediatr 2008;167:793-799.
145. Roldan B, Escobar-Morreale HF, Barrio R, de La Calle H, Alonso M, Garcia-Robles R, Sancho J. Identification of the source of androgen excess in hyperandrogenic type 1 diabetic patients. Diabetes Care 2001;24:1297-1299.
146. Rossetti L, Giaccari A, DeFronzo RA. Glucose toxicity. Diabetes Care 1990; 13:610-630.
147. Sacerdote A, Bleicher SJ. Oral contraceptives abolish luteal phase exacerbation of hyperglycemia in type I diabetes. Diabetes Care 1982;5:651-652.
148. Salardi S, Tonioli S, Tassoni P, Tellarini M, Mazzanti L, Cacciari E. Growth and growth factors in diabetes mellitus. Arch Dis Child 1987;62:57-62.
149. Salerno M, Argenziano A, Di Maio S, Gasparini N, Formicola S, De Filippo G, Tenore A. Pubertal growth, sexual maturation, and final height in children with IDDM. Effects of age at onset and metabolic control. Diabetes Care 1997; 20:721-724.
150. Salonia A, Lanzi R, Scavini M, Pontillo M, Gatti E, Petrella G, Licata G, Nappi RE, Bosi E, Briganti A et al. Sexual function and endocrine profile in fertile women with type 1 diabetes. Diabetes Care 2006;29:312-316.
151. Salvi R, Castillo E, Voirol MJ, Glauser M, Rey JP, Gaillard RC, Vollenweider P, Pralong FP. Gonadotropin-releasing hormone-expressing neurons immortalized conditionally are activated by insulin: implication of the mitogen-activated protein kinase pathway. Endocrinology 2006;147:816-826.
152. Samara-Boustani D, Colmenares A, Elie C, Dabbas M, Beltrand J, Caron V, Ricour C, Jacquin P, Tubiana-Rufi N, Levy-Marchal C et al. High prevalence of hirsutism and menstrual disorders in obese adolescent girls and adolescent girls with type 1 diabetes mellitus despite different hormonal profiles. Eur J Endocrinol 2012; 166:307-316.
153. Schriock EA, Winter RJ, Traisman HS. Diabetes mellitus and its effects on menarche. J Adolesc Health Care 1984;5:101-104.
154. Schroeder B, Hertweck SP, Sanfilippo JS, Foster MB. Correlation between glycemic control and menstruation in diabetic adolescents. J Reprod Med 2000;45:1-5.
155. Schweiger B, Klingensmith GJ, Snell-Bergeon JK. Menarchal timing in type 1 diabetes through the last 4 decades. Diabetes Care 2010;33:2521-2523.
156. Scott AR, Macdonald IA, Bowman CA, Jeffcoate WJ. Effect of phase of menstrual cycle on insulin sensitivity, peripheral blood flow and cardiovascular responses to hyperinsulinaemia in young women with type 1 diabetes. Diabet Med 1990; 7:57-62.
157. Secrest AM, Becker DJ, Kelsey SF, LaPorte RE, Orchard TJ. All-cause mortality trends in a large population-based cohort with long-standing childhood-onset type 1 diabetes: the Allegheny County type 1 diabetes registry. Diabetes Care 2010;33:2573-2579.
158. Sennik DK, Clark J, Foster K, Zachariah S. Catamenial hyperglycaemia: an important cause of recurrent diabetic ketoacidosis. Practical Diabetes Int 2010;27:385-386.
159. Sexton WJ, Jarow JP. Effect of diabetes mellitus upon male reproductive function. Urology 1997;49:508-513.
160. Shishko PI, Kovalev PA, Goncharov VG, Zajarny IU. Comparison of peripheral and portal (via the umbilical vein) routes of insulin infusion in IDDM patients. Diabetes 1992;41:1042-1049.
161. Sir-Petermann T, Codner E, Maliqueo M, Echiburu B, Hitschfeld C, Crisosto N, Perez-Bravo F, Recabarren SE, Cassorla F. Increased anti-Mullerian hormone serum concentrations in prepubertal daughters of women with polycystic ovary syndrome. J Clin Endocrinol Metab 2006;91:3105-3109.
162. Sir-Petermann T, Hitchsfeld C, Codner E, Maliqueo M, Iniguez G, Echiburu B, Sanchez F, Crisosto N, Cassorla F. Gonadal function in low birth weight infants: a pilot study. J Pediatr Endocrinol Metab 2007;20:405-414.
163. Sir-Petermann T, Codner E, Perez V, Echiburu B, Maliqueo M, Ladron de Guevara A, Preisler J, Crisosto N, Sanchez F, Cassorla F et al. Metabolic and reproductive features before and during puberty in daughters of women with polycystic ovary syndrome. J Clin Endocrinol Metab 2009;94:1923-1930.
164. Sirotkin AV. Growth factors controlling ovarian functions. J Cell Physiol 2011; 226:2222-2225.
165. Sjoberg L, Pitkaniemi J, Harjutsalo V, Haapala L, Tiitinen A, Tuomilehto J, Kaaja R. Menopause in women with type 1 diabetes. Menopause 2011;18:158-163.
166. Snajderova M, Martinek J, Horejsi J, Novakova D, Lebl J, Kolouskova S. Premenarchal and postmenarchal girls with insulin-dependent diabetes mellitus: ovarian and other organ-specific autoantibodies, menstrual cycle. J Pediatr Adolesc Gynecol 1999;12:209-214.
167. Snell-Bergeon JK, Dabelea D, Ogden LG, Hokanson JE, Kinney GL, Ehrlich J, Rewers M. Reproductive history and hormonal birth control use are associated with coronary calcium progression in women with type 1 diabetes mellitus. J Clin Endocrinol Metab 2008;93:2142-2148.
168. Soedamah-Muthu SS, Fuller JH, Mulnier HE, Raleigh VS, Lawrenson RA, Colhoun HM. All-cause mortality rates in patients with type 1 diabetes mellitus compared with a non-diabetic population from the UK general practice research database, 1992-1999. Diabetologia 2006;49:660-666.
169. Soliman AT, Omar M, Assem HM, Nasr IS, Rizk MM, El Matary W, El Alaily RK. Serum leptin concentrations in children with type 1 diabetes mellitus: relationship to body mass index, insulin dose, and glycemic control. Metabolism 2002;51:292-296.
170. Solomon CG, Hu FB, Dunaif A, Rich-Edwards J, Willett WC, Hunter DJ, Colditz GA, Speizer FE, Manson JE. Long or highly irregular menstrual cycles as a marker for risk of type 2 diabetes mellitus. J Am Med Assoc 2001;286:2421-2426.
171. Solomon CG, Hu FB, Dunaif A, Rich-Edwards JE, Stampfer MJ, Willett WC, Speizer FE, Manson JE. Menstrual cycle irregularity and risk for future cardiovascular disease. J Clin Endocrinol Metab 2002;87:2013-2017.
172. Soto N, Iniguez G, Lopez P, Larenas G, Mujica V, Rey RA, Codner E. Anti-Mullerian hormone and inhibin B levels as markers of premature ovarian aging and transition to menopause in type 1 diabetes mellitus. Hum Reprod 2009; 24:2838-2844.
173. South SA, Asplin CM, Carlsen EC, Booth RA Jr, Weltman JY, Johnson ML, Veldhuis JD, Evans WS. Alterations in luteinizing hormone secretory activity in women with insulin-dependent diabetes mellitus and secondary amenorrhea. J Clin Endocrinol Metab 1993;76:1048-1053.
174. Sowers MR, Eyvazzadeh AD, McConnell D, Yosef M, Jannausch ML, Zhang D, Harlow S, Randolph JF Jr. Anti-Mullerian hormone and inhibin b in the definition of ovarian aging and the menopause transition. J Clin Endocrinol Metab 2008;93:3478-3483.
175. Spindler-Vomachka M, Johnson DC. Altered hypothalamic-pituitary function in the adult female rat with streptozotocin-induced diabetes. Diabetologia 1985; 28:38-44.
176. Steel JM, Johnstone SD, Corrie JE. Early assessment of gestation in diabetics. Lancet 1984;2:975-976.
177. Steger RW, Rabe MB. The effect of diabetes mellitus on endocrine and reproductive function. Proc Soc Exp Biol Med 1997;214:1-11.
178. Steger RW, Amador A, Lam E, Rathert J, Weis J, Smith MS. Streptozotocin-induced deficits in sex behavior and neuroendocrine function in male rats. Endocrinology 1989;124:1737-1743.
179. Steger RW, Kienast SG, Pillai S, Rabe M. Effects of streptozotocin-induced diabetes on neuroendocrine responses to ovariectomy and estrogen replacement in female rats. Neuroendocrinology 1993;57:525-531.
180. Strotmeyer ES, Steenkiste AR, Foley TP Jr, Berga SL, Dorman JS. Menstrual cycle differences between women with type 1 diabetes and women without diabetes. Diabetes Care 2003;26:1016-1021.
181. Szadkowska A, Pietrzak I, Mianowska B, Bodalska-Lipinska J, Keenan HA, Toporowska-Kowalska E, Mlynarski W, Bodalski J. Insulin sensitivity in Type 1 diabetic children and adolescents. Diabet Med 2008;25:282-288.
182. Tatone C, Carbone MC, Campanella G, Festuccia C, Artini PG, Talesa V, Focarelli R, Amicarelli F. Female reproductive dysfunction during ageing: role of methylglyoxal in the formation of advanced glycation endproducts in ovaries of reproductively-aged mice. J Biol Regul Homeost Agents 2010;24:63-72.
183. Tattersall RB, Pyke DA. Growth in diabetic children. Studies in identical twins. Lancet 1973;2:1105-1109.
184. Taylor CT. Review: diabetes and assisted reproductive technology. Br J Diab Vasc Dis 2002;2:247-253.
185. Tellez R, Frenkel J. Clinical evaluation of body hair in healthy women. Rev Med Chil 1995;123:1349-1354.
186. Tena-Sempere M. Roles of ghrelin and leptin in the control of reproductive function. Neuroendocrinology 2007;86:229-241.
187. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 1993; 329:977-986.
188. Thonneau P, Marchand S, Tallec A, Ferial ML, Ducot B, Lansac J, Lopes P, Tabaste JM, Spira A. Incidence and main causes of infertility in a resident population (1,850,000) of three French regions (1988-1989). Hum Reprod 1991;6:811-816.
189. Tsigkou A, Marzotti S, Borges L, Brozzetti A, Reis F, Candeloro P, Luisa Bacosi M, Bini V, Petraglia F, Falorni A. High serum inhibin concentration discriminates autoimmune oophoritis from other forms of primary ovarian insufficiency. J Clin Endocrinol Metab 2008;93:1263-1269.
190. Tylleskar K, Tuvemo T, Gustafsson J. Diabetes control deteriorates in girls at cessation of growth: relationship with body mass index. Diabet Med 2001; 18:811-815.
191. Uenoyama Y, Tsukamura H, Maeda KI. Kisspeptin/metastin: a key molecule controlling two modes of gonadotrophin-releasing hormone/luteinising hormone release in female rats. J Neuroendocrinol 2009;21:299-304.
192. Valdes CT, Elkind-Hirsch KE, Rogers DG, Adelman JP. The hypothalamic-pituitary axis of streptozotocin-induced diabetic female rats is not normalized by estradiol replacement. Endocrinology 1991;128:433-440.
193. Vehik K, Dabelea D. The changing epidemiology of type 1 diabetes: why is it going through the roof? Diabetes Metab Res Rev 2011;27:3-13.
194. Virdis R, Zampolli M, Street ME, Vanelli M, Potau N, Terzi C, Ghizzoni L, Ibanez L. Ovarian 17 alpha-hydroxyprogesterone responses to GnRH analog testing in oligomenorrheic insulin-dependent diabetic adolescents. Eur J Endocrinol 1997; 136:624-629.
195. Volpi R, Chiodera P, Gramellini D, Capretti L, Caffarri G, Speroni G, Vescovi PP, Coiro V. Influence of residual insulin secretion and duration of diabetes mellitus on the control of luteinizing hormone secretion in women. Eur J Clin Invest 1998;28:819-825.
196. Vuorinen-Markkola H, Koivisto VA, Yki-Jarvinen H. Mechanisms of hyperglycemia-induced insulin resistance in whole body and skeletal muscle of type I diabetic patients. Diabetes 1992;41:571-580.
197. Wahab F, Ullah F, Chan YM, Seminara SB, Shahab M. Decrease in hypothalamic Kiss1 and Kiss1r expression: a potential mechanism for fasting-induced suppression of the HPG axis in the adult male rhesus monkey (Macaca mulatta). Horm Metab Res 2011;43:81-85.
198. Walsh CH, Malins JM. Menstruation and control of diabetes. Br Med J 1977; 2:177-179.
199. Weiss DJ, Charles MA, Dunaif A, Prior DE, Lillioja S, Knowler WC, Herman WH. Hyperinsulinemia is associated with menstrual irregularity and altered serum androgens in Pima Indian women. Metabolism 1994;43:803-807.
200. Whitworth KW, Baird DD, Stene LC, Skjaerven R, Longnecker MP. Fecundability among women with type 1 and type 2 diabetes in the Norwegian Mother and Child Cohort Study. Diabetologia 2011;54:516-522.
201. Widom B, Diamond MP, Simonson DC. Alterations in glucose metabolism during menstrual cycle in women with IDDM. Diabetes Care 1992;15: 213-220.
202. Williams RM, Ward CE, Hughes IA. Premature adrenarche. Arch Dis Child 2012; 97:250-254.
203. Willis D, Mason H, Gilling-Smith C, Franks S. Modulation by insulin of follicle-stimulating hormone and luteinizing hormone actions in human granulosa cells of normal and polycystic ovaries. J Clin Endocrinol Metab 1996;81: 302-309.
204. Yeshaya A, Orvieto R, Dicker D, Karp M, Ben-Rafael Z. Menstrual characteristics of women suffering from insulin-dependent diabetes mellitus. Int J Fertil Menopausal Stud 1995;40:269-273.
205. Yki-Jarvinen H, Makimattila S, Utriainen T, Rutanen EM. Portal insulin concentrations rather than insulin sensitivity regulate serum sex hormone-binding globulin and insulin-like growth factor binding protein 1 in vivo. J Clin Endocrinol Metab 1995; 80:3227-3232.